MENU
+Compare
BGLAF
Stock ticker: OTC
AS OF
Dec 3 closing price
Price
$9.58
Change
-$0.92 (-8.76%)
Capitalization
1B

BGLAF Biogaia AB Forecast, Technical & Fundamental Analysis

BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for BGLAF with price predictions
Dec 17, 2024

BGLAF sees MACD Histogram crosses below signal line

BGLAF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 03, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 5 instances where the indicator turned negative. In of the 5 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on BGLAF as a result. In of 6 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.650) is normal, around the industry mean (57.958). P/E Ratio (25.575) is within average values for comparable stocks, (89.727). BGLAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.014) settles around the average of (0.122) among similar stocks. P/S Ratio (8.772) is also within normal values, averaging (19.472).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BGLAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGLAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbroplan 3A
Phone
+46 855529300
Employees
212
Web
https://www.biogaia.se
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEFNX10.73N/A
N/A
MassMutual Mid Cap Growth R3
WFAIX39.64-0.10
-0.25%
Allspring Index Asset Allocation Admin
MPLAX13.42-0.05
-0.37%
Praxis International Index A
POEIX10.45-0.08
-0.76%
Principal Origin Emerging Markets Instl
SGPSX87.34-1.20
-1.36%
ProFunds Small Cap Growth Svc

BGLAF and Stocks

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-2.26%
CTTH - BGLAF
28%
Poorly correlated
+0.04%
CRYM - BGLAF
22%
Poorly correlated
+11.01%
SHPH - BGLAF
8%
Poorly correlated
-9.54%
DHBUF - BGLAF
5%
Poorly correlated
-2.65%
More

Groups containing BGLAF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
Pharmaceuticals
category (308 stocks)
5%
Poorly correlated
-1.42%
Pharmaceuticals: Other
category (226 stocks)
4%
Poorly correlated
-1.49%